BlueRock Therapeutics says that its Phase I trial
Author: Michael
Fractyl Health has revealed preclinical results f
Manjit Sareen reflects on the first Asia-Pacific
Vaccine selectively targets toxic forms of amylo
Harness Therapeutics has unveiled its second-gene
Algen Biotechnologies is combining CRISPR and AI
Algen Biotechnologies is combining CRISPR and AI
At LIC 2025, investors, scientists and founders
The DripBar, an intravenous vitamin therapy franc
The DripBar, an intravenous vitamin therapy franc